|
|
Symbol | Name | Industry | Sector | Exchange | Cap | Cap, mln | Last | Change | Change, % | Volume |
|
Agilent Technologies Inc | Diagnostics & Research | Healthcare | NYSE | Large | 33,258 |
118.06 |
-0.96 | -0.81 | 69,736 |
|
Alternative Access First Priority CLO Bond Etf | Exchange Traded Fund | Financial Services Etf | NYSE | | |
24.95 |
-0.03 | -0.12 | 15,568 |
|
Innovator Equity Defined Protection Etf - 2 Yr to April 2026 | Exchange Traded Fund | Financial Services Etf | NYSE | | |
26.98 |
0.08 | 0.3 | 495 |
|
American Assets Trust Inc | REIT - Diversified | Real Estate | NYSE | Small | 1,561.02 |
20.43 |
0.03 | 0.15 | 12,606 |
|
iShares MSCI All Country Asia ex Japan Etf | Exchange Traded Fund | Financial Services Etf | NASDAQ | | |
80.67 |
-0.47 | -0.58 | 10,021 |
|
Absolute Select Value Etf | Exchange Traded Fund | Financial Services Etf | NYSE | | |
34.57 |
0.06 | 0.17 | 8,051 |
|
Asbury Automotive Group Inc | Auto & Truck Dealerships | Consumer Cyclical | NYSE | Mid | 4,570.57 |
237.58 |
-2.4 | -1 | 2,027 |
|
Abbott Laboratories | Medical Devices | Healthcare | NYSE | Mega | 235,957 |
132.48 |
-1.53 | -1.14 | 351,246 |
|
Aurora Cannabis Inc | Drug Manufacturers - Specialty & Generic | Healthcare | NASDAQ | Small | 322.08 |
6.06 |
-0.09 | -1.46 | 183,029 |
|
ProFrac Holding Corp | Oil & Gas Equipment & Services | Energy | NASDAQ | Small | 1,465.63 |
10.25 |
0.43 | 4.38 | 148,678 |
Please sign up to view the complete list of stocks. |
|
|
MACD - Technical Analysis from A to Z
The MACD (Moving Average Convergence/Divergence) is a trend-following momentum indicator that shows the relationship between two moving averages of prices. The MACD is the difference between a 26-day and 12-day exponential moving average. A 9-day exponential moving average called the "signal" line is plotted on top of the MACD to show buy or sell opportunities. The MACD proves most effective in wide-swinging trading markets. There are three popular ways to use the MACD: crossovers, overbought/oversold conditions, and divergences.
|
|
| |